首页> 外文会议>International Conference on Remote Sensing, Environment and Transportation Engineering >Lipid lowering activity of (E)-3-4-2-(4-chlorophenoxy)-2-methylpropanoylox y-3-methoxyphenyl acrylic acid (AZ) in hyperlipidemic rats
【24h】

Lipid lowering activity of (E)-3-4-2-(4-chlorophenoxy)-2-methylpropanoylox y-3-methoxyphenyl acrylic acid (AZ) in hyperlipidemic rats

机译:(e)-3- 4- 2-(4-(4-(4-(4-(4-(4-(4-(4-(4-氯苯氧基)-2-甲基丙醇氧洛洛洛洛洛昔洛洛洛豆酸(AZ)的脂质降低活性在高脂血症大鼠中

获取原文

摘要

Hyperlipidemia is closely related to Cardiovascular Disease, and also an important risk factor to affect Atherosclerosis, Coronary Heart Disease (CHD) and other Cardiovascular Disease. And hyperlipidemia could severely affect the health of human. In order to find better biological activity of lowering blood-lipids, we introduced the target compound of AZ. The lead compound were designed and synthesized by chlorophenoxy isobutyric acid of chemical lowering blood-lipid drugs and ferulic acid which is traditional Chinese medicine active products. The structure of the target compound prepared were confirmed by IR, MS, 1H-NMR, and elemental analysis. The herbicidal results show that the target compound has good lowering hyperlipidemia activities.
机译:高脂血症与心血管疾病密切相关,也是影响动脉粥样硬化,冠心病(CHD)和其他心血管疾病的重要危险因素。 高脂血症可能会严重影响人类的健康。 为了找到降低血脂的更好的生物活性,我们介绍了AZ的目标化合物。 通过化学降低血脂药物和阿魏酸的氯苯氧基异丁酸设计和合成了铅化合物,该血脂药物和阿魏酸是中药活性产物。 由IR,MS,1H-NMR和元素分析证实制备的目标化合物的结构。 除草结果表明,目标化合物具有良好的降低的高脂血症活动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号